RxDoctor Payments Data

Casey Burnette

Gerontology · Pinehurst, NCNPI 1063906584

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 51.7% of the total.

$2,507in general payments, 2019–2025

Across 112 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$290
  • Gilead$135
  • Takeda Pharmaceuticals U.S.A., Inc.$123
  • Merck$92
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$86
  • plus $484 from 15 others

What the payments were for

  • Food & beverage$2,40696%
  • Education$1014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,507 in reported general payments places this provider in the 85th percentile of 165 gerontology providers in North Carolina.

See all gerontology providers in North Carolina

Medicare billing

Part B allowed, 2024
$51,625
Medicare patients
359
Services billed
997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide81$45,066
MotegrityPrucalopride Succinate14$7,684
TrulancePlecanatide11$6,061
Lubiprostone19$3,457
Omeprazole222$3,429
Sucralfate31$2,727
Colestipol Hcl44$2,355
Esomeprazole Magnesium72$2,075
Rabeprazole Sodium45$1,748
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates22$1,389
Pantoprazole Sodium117$1,297
Budesonide DrBudesonide13$1,055
Lansoprazole19$797
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg22$512
Lidocaine Hcl ViscousLidocaine Hcl22$495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,297$45,06681 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$123$7,68414 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$86$6,06111 claims
SandozLansoprazole$21$79719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 165 gerontology providers in North Carolina.

Other gerontology in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →